Početna › Nemikrocelularni karcinom pluća
Kliničke studije za Nemikrocelularni karcinom pluća koje traže sudionike u SAD-u
429 studija za Nemikrocelularni karcinom pluća traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Houston, TX145 studija
- New York City, NY120 studija
- Arlington, VA104 studija
- Nashville, TN97 studija
- Boston, MA90 studija
- Los Angeles, CA87 studija
- St. Louis, MO73 studija
- Chicago, IL61 studija
- Baltimore, MD60 studija
- San Antonio, TX59 studija
- Columbus, OH56 studija
- Washington, DC55 studija
- Seattle, WA53 studija
- Dallas, TX52 studija
- Tampa, FL51 studija
- Philadelphia, PA51 studija
- Queens, NY49 studija
- Pittsburgh, PA48 studija
- San Diego, CA48 studija
- Atlanta, GA47 studija
- Edison, NJ47 studija
- Portland, OR46 studija
- Santa Monica, CA45 studija
- Grand Rapids, MI44 studija
- Detroit, MI44 studija
- Orlando, FL44 studija
- Cleveland, OH43 studija
- New Haven, CT41 studija
- Durham, NC39 studija
- Jacksonville, FL39 studija
- Rochester, MN37 studija
- Baldwin Park, CA36 studija
- San Francisco, CA36 studija
- Cincinnati, OH35 studija
- Indianapolis, IN32 studija
- Kansas City, MO31 studija
- Miami, FL31 studija
- Salt Lake City, UT31 studija
- Aurora, CO30 studija
- Austin, TX30 studija
Po državama
- Alabama36 studija
- Aljaska11 studija
- Arizona66 studija
- Arkansas34 studija
- Colorado73 studija
- Connecticut55 studija
- Delaware21 studija
- Distrikt Columbia38 studija
- Florida155 studija
- Georgia73 studija
- Havaji10 studija
- Idaho18 studija
- Illinois94 studija
- Indiana49 studija
- Iowa29 studija
- Kalifornija207 studija
- Kansas34 studija
- Kentucky46 studija
- Louisiana26 studija
- Maine16 studija
- Maryland76 studija
- Massachusetts102 studija
- Michigan101 studija
- Minnesota69 studija
- Mississippi20 studija
- Missouri86 studija
- Montana18 studija
- Nebraska40 studija
- Nevada25 studija
- New Hampshire17 studija
- New Jersey88 studija
- New Mexico22 studija
- New York169 studija
- North Carolina79 studija
- North Dakota15 studija
- Ohio121 studija
- Oklahoma31 studija
- Oregon60 studija
- Pennsylvania103 studija
- Rhode Island13 studija
- South Carolina30 studija
- South Dakota20 studija
- Tennessee118 studija
- Texas204 studija
- Utah56 studija
- Vermont7 studija
- Virginia137 studija
- Washington84 studija
- West Virginia14 studija
- Wisconsin45 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04267848A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06623422Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT02146170Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06472245A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07293247The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04585750A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06465069A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07680764Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07751042A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07365319A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT05176483Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06918132A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06780085A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07513376A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07189871A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07090499Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07388524A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07155187Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06625775A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06907615A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07554339A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07190248Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.